Life ScienceCompany
Aimmune Therapeutics Ownership
Who owns Aimmune Therapeutics?
Aimmune Therapeutics is owned by Nestlé Health Science SA. It was acquired on August 31, 2020.
Was Aimmune Therapeutics formerly PE-backed?
Yes. Aimmune Therapeutics was formerly owned by 1 private investor.
Aimmune Therapeutics Business Overview
Where is Aimmune Therapeutics headquartered?
Aimmune Therapeutics is headquartered in Brisbane, California.
What sector is Aimmune Therapeutics in?
Aimmune Therapeutics is a life science company.
When was Aimmune Therapeutics founded?
Aimmune Therapeutics was founded in 2011.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.